Difference between revisions of "AAP Circumcision Task Force 2012"
Jump to navigation
Jump to search
m |
m (add interlanguage link) |
||
| Line 1: | Line 1: | ||
The persons listed here are members of the [[American_Academy_of_Pediatrics|American Academy of Pediatrics]] Task Force responsible for the 2012 Policy Statement on Circumcision, as listed at the end of the Policy Statement.<ref>{{REFweb | The persons listed here are members of the [[American_Academy_of_Pediatrics|American Academy of Pediatrics]] Task Force responsible for the 2012 Policy Statement on Circumcision, as listed at the end of the Policy Statement.<ref>{{REFweb | ||
| − | | quote=Task Force on Circumcision | + | |quote=Task Force on Circumcision |
| − | | url=http://pediatrics.aappublications.org/content/early/2012/08/22/peds.2012-1989.abstract | + | |url=http://pediatrics.aappublications.org/content/early/2012/08/22/peds.2012-1989.abstract |
| − | | title=Circumcision Policy Statement | + | |title=Circumcision Policy Statement |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=American Academy of Pediatrics | + | |publisher=American Academy of Pediatrics |
| − | | website=United States of America | + | |website=United States of America |
| − | | date= | + | |date= |
| − | | accessdate=2012-08-27 | + | |accessdate=2012-08-27 |
}}</ref> | }}</ref> | ||
| Line 40: | Line 40: | ||
Members of the Task Force on circumcision 1998-1999<ref>{{REFweb | Members of the Task Force on circumcision 1998-1999<ref>{{REFweb | ||
| − | | quote=Task Force on Circumcision 1999 | + | |quote=Task Force on Circumcision 1999 |
| − | | url=http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html | + | |url=http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html |
| − | | title=Circumcision Policy Statement 1999 | + | |title=Circumcision Policy Statement 1999 |
| − | | last= | + | |last= |
| − | | first= | + | |first= |
| − | | publisher=American Academy of Pediatrics | + | |publisher=American Academy of Pediatrics |
| − | | website=United States of America | + | |website=United States of America |
| − | | date= | + | |date= |
| − | | accessdate=2012-09-26 | + | |accessdate=2012-09-26 |
}}</ref> | }}</ref> | ||
{{Citation | {{Citation | ||
| − | | Title=Summary of Policy Statement 1999 | + | |Title=Summary of Policy Statement 1999 |
| − | | Text=Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy. | + | |Text=Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy. |
| − | | Author= | + | |Author= |
| − | | Source= | + | |Source= |
| − | + | |ref=<ref>http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html</ref> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | | ref=<ref>http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html</ref> | ||
}} | }} | ||
| Line 78: | Line 73: | ||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
| + | |||
| + | [[de:{{FULLPAGENAME}}]] | ||
Revision as of 18:19, 17 November 2019
The persons listed here are members of the American Academy of Pediatrics Task Force responsible for the 2012 Policy Statement on Circumcision, as listed at the end of the Policy Statement.[1]
Contents
Task Force on Circumcision 2012
- Susan Blank, MD, MPH, Chairperson
- Michael Brady, MD, Representing the Committee on Pediatric AIDS
- Ellen Buerk, MD, Representing the AAP Board of Directors
- Waldemar Carlo, MD, Representing the AAP Committee on Fetus and Newborn
- Douglas Diekema, MD, MPH, Representing the AAP Committee on Bioethics
- Andrew Freedman, MD, Representing the AAP Section on Urology
- Lynne Maxwell, MD, Representing the AAP Section on Anesthesiology and Pain Medicine
- Steven Wegner, MD, JD, Representing the AAP Committee on Child Health Financing
Liaisons
- Charles LeBaron, MD – Centers for Disease Control and Prevention
- Lesley Atwood, MD – American Academy of Family Physicians
- Sabrina Craigo, MD – American College of Obstetricians and Gynecologists
Consultants
- Susan K. Flinn, MA – Medical Writer
- Esther C. Janowsky, MD, PhD
Staff
- Edward P. Zimmerman, MS
Task Force on Circumcision 1999
Members of the Task Force on circumcision 1998-1999[2]
| “ | Summary of Policy Statement 1999 Existing scientific evidence demonstrates potential medical benefits of newborn male circumcision; however, these data are not sufficient to recommend routine neonatal circumcision. In the case of circumcision, in which there are potential benefits and risks, yet the procedure is not essential to the child’s current well-being, parents should determine what is in the best interest of the child. To make an informed choice, parents of all male infants should be given accurate and unbiased information and be provided the opportunity to discuss this decision. It is legitimate for parents to take into account cultural, religious, and ethnic traditions, in addition to the medical factors, when making this decision. Analgesia is safe and effective in reducing the procedural pain associated with circumcision; therefore, if a decision for circumcision is made, procedural analgesia should be provided. If circumcision is performed in the newborn period, it should only be done on infants who are stable and healthy.[3] |
- Carole M. Lannon, MD, MPH, Chairperson
- Ann Geryl Doll Bailey, MD
- Alan R. Fleischman, MD
- George W. Kaplan, MD
- Craig T. Shoemaker, MD
- Jack T. Swanson, MD
- Donald Coustan, MD
References
- ↑
Circumcision Policy Statement
, United States of America, American Academy of Pediatrics. Retrieved 27 August 2012.
Quote:Task Force on Circumcision
- ↑
Circumcision Policy Statement 1999
, United States of America, American Academy of Pediatrics. Retrieved 26 September 2012.
Quote:Task Force on Circumcision 1999
- ↑ http://pediatrics.aappublications.org/content/103/3/686.full.pdf+html
